Human Subjects Protection & Research Ethics
Human subjects protection covers the institutional structures and regulatory requirements that govern research involving living people as participants. At its center is the Institutional Review Board (IRB) — or, outside the United States, the research ethics committee — which reviews proposed studies before they begin to weigh risks to participants against anticipated benefits and to confirm that informed consent processes are adequate. This sub-cluster organizes material around three layers: the historical foundations that explain why this oversight exists, the regulatory text that operationalizes it, and the practical administration of ethics review within institutions. The historical layer traces to documented abuses of research subjects in the twentieth century and the ethical principles articulated in response, most notably the Belmont Report's framework of respect for persons, beneficence, and justice. The regulatory layer in the US centers on the Common Rule (45 CFR 46), the federal policy that defines IRB composition, review categories (exempt, expedited, full board), and consent requirements; comparable frameworks apply in other jurisdictions. The administrative layer covers how research-administration offices actually run this process: protocol submission and amendment tracking, continuing review, reportable events, and the credentialing of IRB staff and members. Pages in this sub-cluster draw on the curriculum used by PRIM&R's Human Research Protections Program (HRPP) training and the CITI Program's Human Subjects Research (HSR) course track, which together represent the standard professional-development pathway for IRB administrators and coordinators in the US research-administration field.
Guides
Kenya’s National Research-Ethics Framework: NACOSTI Accreditation and NCST Guidelines
How NACOSTI accredits Kenya’s Institutional Scientific and Ethics Review Committees (ISERCs), how the 2004 NCST biomedical research ethics guidelines still apply, and how ethical clearance feeds into NACOSTI’s research licensing process.
Adverse Event Reporting to the IRB: What Must Be Reported, and When
Not every adverse event has to be reported to the IRB, and IRB reporting is a separate track from sponsor/FDA safety reporting. This guide explains the OHRP three-part unanticipated-problem test, who reports what and when, and how AE reporting connects to continuing review.
Exculpatory Language in Informed Consent: What It Is and Why It’s Prohibited
Exculpatory language — wording that makes a research subject waive legal rights or release the sponsor/investigator from liability for negligence — is prohibited in every informed consent document under 45 CFR 46.116(a)(6) and 21 CFR 50.20. This guide explains the prohibition, gives acceptable-vs-prohibited examples, and distinguishes it from waiver of consent and LAR-related consent.
Retrospective Chart Review: IRB Requirements, Exemptions, and Consent Waivers
How to determine whether a retrospective chart review qualifies for IRB exemption, expedited review, or full-board review, and how consent and HIPAA authorization waivers apply.
Is My Project Human Subjects Research? A Step-by-Step Determination Process
A step-by-step walkthrough of how the human subjects research determination actually works: self-screening, submitting for an official IRB/HRPP determination, the four possible outcomes, documentation, and engagement determination for multi-site projects.
IRB Member Roles and Required Composition: Who Sits on the Board and Why
Federal regulation dictates exactly who must sit on an IRB: at least five members, a scientist, a non-scientist, and a non-affiliated community member, plus rules on conflicts of interest and vulnerable-population expertise. Here is what 45 CFR 46.107 and 21 CFR 56.107 actually require.
Secondary Use of Identifiable Data and Biospecimens: The Regulatory Pathways
How researchers can lawfully reuse identifiable data and biospecimens collected for an earlier study: the Common Rule’s secondary-research exemption, IRB waiver of consent, prospective broad consent, and how HIPAA runs alongside the Common Rule.
How to Amend an IRB-Approved Protocol: Process, Timelines, and Common Pitfalls
A step-by-step walkthrough of how to amend an IRB-approved research protocol: what counts as an amendment, expedited vs. full-board review, realistic timelines, the immediate-hazard exception, and when re-consent is required.
Waiver of Documentation of Informed Consent: 45 CFR 46.117(c) Explained
How 45 CFR 46.117(c) lets an IRB waive the signed consent form while the consent process itself still occurs, why that is different from waiving consent entirely, and the FDA-side parallel at 21 CFR 56.109(c)(1).
Waiver of Informed Consent: When an IRB Can Approve Research Without It
A practical guide to when and how an IRB can waive informed consent entirely under 45 CFR 46.116(f) and the 2024 FDA rule at 21 CFR 50.22, including the five required criteria and how it differs from a documentation waiver.
Legally Authorized Representative (LAR) in Research Consent: Who Qualifies and How It Works
A legally authorized representative (LAR) consents to research participation on behalf of a subject who lacks capacity. This guide covers the 45 CFR 46.102(i) and 21 CFR 50.3(l) definitions, who typically qualifies under state law, how LAR differs from a health care proxy or guardian, and what IRBs expect documented.
Deception in Research and Debriefing Requirements
When IRBs allow deception or incomplete disclosure in research, what the Common Rule’s consent-alteration test (45 CFR 46.116(f)) requires, and what a compliant debriefing plan must include.
HIPAA Waiver or Alteration of Authorization for Research Use of PHI
How an IRB or Privacy Board evaluates a HIPAA waiver or alteration of authorization for research use of PHI: the three regulatory criteria, full vs. partial waivers, required documentation, and how this differs from the Common Rule consent waiver.
Forensic Genetic Genealogy in Academic Research: IRB and Ethical Considerations
How institutions should determine whether forensic/investigative genetic genealogy activity is research under the Common Rule, who the “subject” is, and what ethical questions persist regardless of the IRB determination.
Citizen Science and Human-Subjects Regulation: Do Volunteer Contributors Need IRB Review?
Whether citizen-science volunteers trigger Common Rule review depends on their role, not their volunteer status: data collectors about the world are generally outside 45 CFR 46; data subjects, including third parties volunteers collect data about, are not.
Honest Broker: The De-Identified-Data Intermediary Role in Human Subjects Research
What an honest broker is in human subjects research: a neutral third party who de-identifies clinical data before researchers ever access it, why the role exists under HIPAA and the Common Rule, and its limits.
Broad Consent Under 45 CFR 46.116(d): What It Requires
How prospective broad consent for future unspecified secondary research use works under the revised Common Rule at 45 CFR 46.116(d): required elements, limited IRB review, and how it differs from a waiver of consent and from GDPR broad consent.
Quality Improvement vs. Human Subjects Research: How to Determine If You Need IRB Review
Quality improvement and quality assurance projects are not automatically exempt from IRB review, or automatically research. This guide walks through the 45 CFR 46 two-part test, the factors real institutional determination frameworks use (purpose, design, scope — not intent to publish), who should make the call, and how to document it.
IRB Continuing Review: What It Covers and When It’s Required
What IRB continuing review actually covers, when the 2018 Common Rule revisions eliminated it for expedited-eligible research, and the typical submission timeline under 45 CFR 46.109.
Vulnerable Populations Under the Common Rule: Categories and Additional Protections Required
A category-by-category reference to which research subjects require additional Common Rule protections — pregnant women/fetuses/neonates, prisoners, children, plus cognitively impaired and economically/educationally disadvantaged persons — and exactly what each requires.
CRISPR Germline Editing Legal Status by Country (US, UK, China)
A country-by-country survey of the current legal and regulatory status of heritable human germline gene editing in the US, UK, and China, plus WHO’s international governance framework.
IRB Approval Cost: What Institutions and Independent Researchers Actually Pay
Real IRB fee data for three scenarios: institutional review usually folded into overhead, commercial/central IRB fees for industry trials (WCG’s 2026 schedule: $5,900 initial / $3,132 continuing), and what unaffiliated researchers pay out of pocket.
How Long Does IRB Approval Take? Typical Review Timelines by Review Type
Typical IRB review timelines by review type (exempt, expedited, full board), what actually extends them, and how to plan a study timeline around IRB review realistically.
Undue Influence and Vulnerable Populations in Research
How the Common Rule distinguishes coercion, undue influence, and undue inducement; which populations get additional protection under 45 CFR 46 Subparts B, C, and D; and what triggers extra IRB scrutiny.
FWA Lookup: How to Find an Institution’s Federalwide Assurance Number
How to search OHRP’s public database to find an institution’s Federalwide Assurance (FWA) number, read the results, and confirm active status for grants, subrecipient monitoring, and reliance agreements.
The Components of Informed Consent: The Required Elements Under 45 CFR 46.116
The required components of informed consent under 45 CFR 46.116: the eight basic elements, the ninth element added in 2018, and the additional elements required only when appropriate.
What Does an IRB Manager Do? Role, Responsibilities, and Reporting Structure
An IRB Manager runs the IRB office’s operations as a whole — staff supervision, HRPP policy, accreditation, and systems — distinct from the protocol-level work of an IRB Coordinator.
The Human Subjects Section of an NIH Grant: A Worked Example
A worked, illustrative example of the human-subjects portion of NIH’s Human Subjects and Clinical Trials Information form: a filled-in Study Record with sample eligibility criteria, an Inclusion Enrollment Report, and recruitment, risk, and monitoring narrative, clearly labeled as a hypothetical composite.
Informed Consent Checklist for Researchers
A practical, item-by-item checklist for researchers drafting an informed consent process and document under 45 CFR 46.116 — basic and additional required elements, process quality checks, special-population triggers, and documentation requirements.
Social Science Research Ethics: How Review Differs From Biomedical IRB Review
How IRB review of social and behavioral science research differs from biomedical review: the Common Rule exemption categories that most often apply, deception and debriefing requirements, and the minimal-risk calculus for survey, interview, and observational methods.
HRPP Self-Assessment Before Applying for AAHRPP Accreditation
How an HRPP maps current practice against AAHRPP’s Domains, Standards, and Elements, runs a gap analysis, and assembles documentation before formally applying for accreditation.
How to Write a Research Protocol for IRB Submission
How to draft the protocol narrative itself for IRB submission: section order, how much risk/benefit detail reviewers expect, common reasons it gets sent back, and how it differs from a funded grant proposal’s research plan.
CRISPR Ethics: Germline Editing, He Jiankui, and Oversight
The bioethics debate over CRISPR gene editing: the somatic-vs-germline distinction, the 2018 He Jiankui case and its legal outcome, international moratorium calls, and how US and Chinese regulation actually works today.
Informed Consent Form: A Worked Example With Annotations
A section-by-section worked example of an informed consent form, annotated against the 45 CFR 46.116 required elements and ICH E6 disclosure expectations. Illustrative composite, not an IRB-approved template.
PHS Human Subjects and Clinical Trials Information Form: What It Requires and When It’s Triggered
How NIH’s PHS Human Subjects and Clinical Trials Information form works: the baseline section every applicant completes, the fuller sections triggered by human subjects research, and the additional sections triggered by NIH’s clinical-trial definition.
The IRB Application: What to Include, How to Prepare It, and Why It Gets Sent Back
What an IRB application packet actually contains — protocol, consent documents, recruitment materials, HIPAA and data-security sections — how it is filed through electronic IRB systems, and the recurring reasons a submission gets sent back for revision.
Ethics of Embryonic Stem Cell Research: Dickey-Wicker, NIH Guidelines, and ISSCR Standards
A practical guide to the ethics and regulation of embryonic stem cell research: what the Dickey-Wicker Amendment actually restricts, how the 2009 NIH Guidelines for Human Stem Cell Research and the human Pluripotent Stem Cell Registry work, and what changed in the 2021 ISSCR Guidelines.
When Should Informed Consent Be Obtained? Timing, Re-Consent, and the Emergency Exception
Consent must be obtained prospectively, before any study-related procedure begins. This guide covers that timing rule, when a protocol amendment triggers re-consent, and the narrow 21 CFR 50.24 / 45 CFR 46.101(i) exception allowing emergency research without prior consent.
NHMRC’s National Statement on Ethical Conduct in Human Research: What It Requires
A guide to NHMRC’s National Statement on Ethical Conduct in Human Research: its four core values, risk-based ethics review, HREC structure, and how it differs from the Australian Code for the Responsible Conduct of Research.
Principles of Research Ethics
The codified principles that govern research involving human participants — Belmont’s respect for persons, beneficence, and justice, their codification into the Common Rule, and how they relate to Nuremberg, Helsinki, CIOMS, and RCR.
Informed Consent in Research: What It Requires and How It Works
What informed consent actually requires beyond a signature: voluntary participation, disclosure, comprehension, capacity, and an ongoing right to withdraw — grounded in the Belmont Report and the Common Rule (45 CFR 46), including special-population protections and waiver criteria.
IRB/REC Approval Process: What Needs Review and What Doesn’t
A practical guide to what triggers IRB/REC review, the three review pathways, what is typically exempt, realistic timelines, how the process differs across institution types, and how approval status should be tracked in institutional research information systems.
